ArticleIntestinal research2023

Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial.

Toshifumi Hibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.